Sharekhan

Suraksha Diagnostic Ltd

Tue 1/07/2025,12:19:36 | NSE : SURAKSHA

₹ 332.006.80 (2.09%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 325.20

Previous Close

₹ 325.20

Volume

42891

Mkt Cap ( Rs. Cr)

₹1729.08

High

₹ 335.05

Low

₹ 325.20

52 Week High

₹ 449.00

52 Week Low

₹ 231.00

Book Value Per Share

₹ 38.25

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

44%

Sell Order Quantity

56%

Bid Price

Qty

332.15

25

332.00

14

332.00

15

332.00

161

332.00

2

Bid Total

17978

Bid Price

Qty

332.85

27

333.00

30

333.00

38

333.00

600

334.00

9

Bid Total

22524

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Trading Window-XBRL

    20 Jun 2025, 3:31PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Closure of Trading Window
  • Suraksha Diagnostic - Trading Window

    20 Jun 2025, 3:30PM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Jun 2025, 5:42PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Jun 2025, 5:37PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you of the schedule of the An
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    30 May 2025, 5:48PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    30 May 2025, 5:46PM Audio recording on the Analyst(s) / Investor(s) Meet/ Conference- ''Earnings Call'' held on Friday, 30 May 2025
  • Suraksha Diagnostic - Investor Presentation

    29 May 2025, 1:21PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Copy of Newspaper Publication

    29 May 2025, 1:02PM Suraksha Diagnostic Limited has informed the Exchange about the Newspaper Publication of the audited (standalone & consolidated) financial results of
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    29 May 2025, 1:24PM Investor presentation on the audited (standalone & consolidated) financial results of the Company for the quarter and financial year ended 31 March 20
  • Suraksha Diagnostic - Press Release

    28 May 2025, 11:31PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated May 28, 2025, titled """"Suraksha-Press Release Q4 & FY25"".
  • Suraksha Diagnostic - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    28 May 2025, 8:04PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Change in Management

    28 May 2025, 7:44PM Appointment of Secretarial Auditor and re-appointment of Internal Auditor and Cost Auditor for the financial year 2025-26
  • Suraksha Diagnostic - Change in Auditors

    28 May 2025, 7:32PM Suraksha Diagnostic Limited has informed the Exchange regarding Change in Auditors of the company.
  • Suraksha Diagnostic - Audited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Financial Ye

    28 May 2025, 7:31PM The Board of Directors of the Company in their meeting held on Wednesday, 28 May 2025, has approved the audited (standalone and consolidated) financia
  • Suraksha Diagnostic - Outcome of Board Meeting

    28 May 2025, 7:29PM Suraksha Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on May 28, 2025.
  • Suraksha Diagnostic - Outcome of Board Meeting

    28 May 2025, 7:26PM Suraksha Diagnostic Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Suraksha Diagnostic Q4 net profit up 17.11% at Rs 8.01 cr

    28 May 2025, 7:24PM The company reported standalone net profit of Rs 8.01 crore for the quarter ended March 31, 2025 as compared to Rs 6.84 crore in the same period last
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Wednesday, 28 May 2025

    28 May 2025, 7:14PM Outcome of Board meeting held on 28 May 2025 inter-alia for approval of financial results for the quarter and financial year ended 31 March 2025.
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    24 May 2025, 5:57PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    24 May 2025, 5:54PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conf
  • Suraksha Diagnostic - Board Meeting Intimation

    22 May 2025, 10:09AM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2025 to consider and approve the Yearly Audited Financi
  • Suraksha Diagnostic - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Oblig

    21 May 2025, 5:41PM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider
  • Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    10 Apr 2025, 12:42PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Suraksha Diagnostic - General Updates

    9 Apr 2025, 8:45PM Suraksha Diagnostic Limited has informed the Exchange about an Update on the Acquisition
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    9 Apr 2025, 8:37PM Intimation regarding update on acquisition under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 6:20PM As of March 2025, 48.78% is owned by Indian Promoters and 51.22% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    9 Apr 2025, 12:40PM Dr. Somnath Chatterjee has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa
  • Suraksha Diagnostic - Disclosure under SEBI Takeover Regulations

    9 Apr 2025, 12:19PM Suraksha Diagnostic Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (S
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 12:53PM Suraksha Diagnostic Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 12:46PM Compliance Certificate received from KFin Technologies Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of SEBI (Depo
  • Suraksha Diagnostic - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    8 Apr 2025, 12:37PM SURAKSHA DIAGNOSTIC LIMITED has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL
  • Suraksha Diagnostic - General Updates

    7 Apr 2025, 9:20PM Suraksha Diagnostic Limited has informed the Exchange about an Update on the Acquisition

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 220.1374 189.5015 170.6301 169.0335
Liabilities 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 6.9 6.9 6.9
Gross Profit 82.5903 71.1917 44.9867 47.5072
Net Profit 33.44 24.3839 7.189 23.751
Cash From Operating Activities 62.798 61.23 44.9253 42.3306
NPM(%) 13.42 11.15 3.78 10.64
Revenue 249.0954 218.5247 189.9854 223.1925
Expenses 166.5051 147.333 144.9987 175.6853
ROE(%) 16.78 12.24 3.6 11.92

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 865.00 3.46 28.70 185.57 301.39 0.58
Lotus Eye Hospital and Institute Ltd 71.16 0.00 203.31 676.19 3.55 0.00
Vaishali Pharma Ltd 11.59 -0.09 193.17 348.54 3.13 0.00
Astec Lifesciences Ltd 937.75 1.42 0.00 637.59 -687.10 0.00

Company Info

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of ?300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of ? 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from our Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of ? 30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of ?67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 332.00.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 335.05 and the 52-week low is ₹ 325.20.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1729.08. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT